This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Prognostic impact of CEBPA mutational subgroups in adult AML
Leukemia Open Access 16 January 2024
-
TET2 lesions enhance the aggressiveness of CEBPA-mutant acute myeloid leukemia by rebalancing GATA2 expression
Nature Communications Open Access 04 October 2023
-
Sporadic and Familial Acute Myeloid Leukemia with CEBPA Mutations
Current Hematologic Malignancy Reports Open Access 01 June 2023
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Vicente C, Conchillo A, Garcia-Sanchez MA, Odero MD . The role of the GATA2 transcription factor in normal and malignant hematopoiesis. Crit Rev Oncol Hematol 2012; 82: 1–17.
Zhang SJ, Ma LY, Huang QH, Li G, Gu BW, Gao XD et al. Gain-of-function mutation of GATA-2 in acute myeloid transformation of chronic myeloid leukemia. Proc Natl Acad Sci USA 2008; 105: 2076–2081.
Hahn CN, Chong CE, Carmichael CL, Wilkins EJ, Brautigan PJ, Li XC et al. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat Genet 2011; 43: 1012–1017.
Ostergaard P, Simpson MA, Connell FC, Steward CG, Brice G, Woollard WJ et al. Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome). Nat Genet 2011; 43: 929–931.
Dufour A, Konstandin N, Ksienzyk B, Zellmeier E, Benthaus T, Yaghmaie M et al. High frequency of GATA2 mutations in cytogenetically normal acute myeloid leukemia with biallelic CEBPA mutations identified by exome sequencing. ASH Abstract 2011, 72.
Greif PA, Dufour A, Konstandin NP, Ksienzyk B, Zellmeier E, Tizazu B et al. GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemia. Blood 2012; e-pub ahead of print 30 May 2012.
Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 1998; 92: 2322–2333.
Tong Q, Tsai J, Tan G, Dalgin G, Hotamisligil GS . Interaction between GATA and the C/EBP family of transcription factors is critical in GATA-mediated suppression of adipocyte differentiation. Mol Cell Biol 2005; 25: 706–715.
Acknowledgements
We thank all clinicians for sending samples to our laboratory for diagnostic purposes, and for providing clinical information and follow-up data. In addition, we would like to thank all co-workers at the MLL Munich Leukemia Laboratory for approaching together many aspects in the field of leukemia diagnostics and research. Especially the technical assistance of Madlen Ulke, who performed Sanger Sequencing analyses, is greatly appreciated. In addition, we are grateful for the data management support performed by Tamara Alpermann.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
CH, WK, TH and SuS are equity owners of and AF, CE, VG, AK and FD are employed by the MLL Munich Leukemia Laboratory.
Additional information
Supplementary Information accompanies the paper on the Leukemia website
Supplementary information
Rights and permissions
About this article
Cite this article
Fasan, A., Eder, C., Haferlach, C. et al. GATA2 mutations are frequent in intermediate-risk karyotype AML with biallelic CEBPA mutations and are associated with favorable prognosis. Leukemia 27, 482–485 (2013). https://doi.org/10.1038/leu.2012.174
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2012.174
This article is cited by
-
Prognostic impact of CEBPA mutational subgroups in adult AML
Leukemia (2024)
-
TET2 lesions enhance the aggressiveness of CEBPA-mutant acute myeloid leukemia by rebalancing GATA2 expression
Nature Communications (2023)
-
Sporadic and Familial Acute Myeloid Leukemia with CEBPA Mutations
Current Hematologic Malignancy Reports (2023)
-
Unsupervised meta-clustering identifies risk clusters in acute myeloid leukemia based on clinical and genetic profiles
Communications Medicine (2023)
-
Distinct genomic landscape of Chinese pediatric acute myeloid leukemia impacts clinical risk classification
Nature Communications (2022)